文献速递精神分裂症与精神病性障碍

精神分裂症自我污名:37项研究的系统综述与荟萃分析

Self-stigma in schizophrenia: a systematic review and meta-analysis of 37 studies from 25 high- and low-to-middle income countries.
PubMed 文献 · Mol Psychiatry · 2023-03-08

该研究系统检索并荟萃分析了2007至2020年间25个国家37项研究(n=7717),评估精神分裂症谱系障碍患者自我污名的多个维度及关联因素。结果显示各维度均值在2.14至2.76之间(量表总分1-4),自我污名水平未随时间下降,且与失业、高抗精神病药剂量及低功能状态相关,而经典疾病严重程度指标和年龄、性别、教育等社会人口学变量未显示关联。

要点

  • 自我污名各维度均值在2.14-2.76之间(量表总分1-4),感知污名最高。
  • 失业、高抗精神病药剂量和低功能状态与不同污名维度相关。
  • 疾病严重程度指标及年龄、性别、教育未显示与自我污名关联。

核心结论

  • 自我污名在精神分裂症患者中处于中等偏高水平,且未随时间下降。
  • 自我污名与失业、高抗精神病药剂量及低功能状态相关,而非经典疾病严重程度指标。

研究设计与样本

  • 系统综述与荟萃分析,检索Medline、Google Scholar和Web of Science至2021年9月,无语言或时间限制。
  • 纳入37项观察性研究(n=7717),来自25个国家(5大洲),发表于2007至2020年,其中20项在高收入国家进行。
  • 纳入标准为≥80%患者诊断为精神分裂症谱系障碍且使用验证量表测量自我污名维度;采用随机效应模型、亚组分析和元回归分析。

主要发现

  • 感知污名均值2.76(95%CI 2.60-2.94),体验污名2.29(95%CI 2.18-2.41),异化2.40(95%CI 2.29-2.52)。
  • 刻板印象认同2.14(95%CI 2.03-2.27),社交回避2.28(95%CI 2.17-2.39),污名抵抗2.53(95%CI 2.43-2.63)。
  • 居住于非城市地区、低收入、单身、失业、高抗精神病药剂量和低功能与不同污名维度相关。
  • 欧洲研究某些污名维度低于其他地区;自我污名水平未随时间降低。
  • 经典疾病严重程度指标(精神病性严重度、发病年龄、病程)及年龄、性别、教育未显示与自我污名关联。

关键数值与推荐

  • 自我污名量表总分范围1-4,各维度均值:感知污名2.76、体验污名2.29、异化2.40、刻板印象认同2.14、社交回避2.28、污名抵抗2.53。

临床怎么用

  • 临床应关注失业、高抗精神病药剂量和低功能状态的精神分裂症患者,其自我污名风险较高。
  • 针对自我污名的干预可考虑个性化措施,而非仅基于疾病严重程度或社会人口学特征。

局限性

  • 原文未明确报告纳入研究的偏倚风险或异质性定量指标。
  • 原文指出仍存在重要未探索因素,需进一步研究以提高公共政策和个性化干预效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In schizophrenia, it is currently thought that stigma experience is increased by psychotic and depressive symptomatology, exposure to stigma at the workplace, and that self-stigma levels vary across countries without knowing the factors explaining these variations. The aim of the present meta-analysis was to synthetize the data of observational studies comprehensively exploring multiple self-stigma dimensions and associated factors. A systematic literature search without language or time restrictions was conducted in Medline, Google Scholar, and Web of Science for studies, last 09/2021. Eligible studies that included ≥80% of patients diagnosed with schizophrenia-spectrum disorders and used a validated scale measuring self-stigma dimensions were meta-analysed using random-effects models, followed by subgroup and meta-regression analyses. Study registration: PROSPERO CRD42020185030. Overall, 37 studies (n = 7717) from 25 countries (5 continents) published between 2007 and 2020 were included, with 20 studies conducted in high-income countries. These studies used two scales with total scores ranging 1-4. The mean estimate of perceived stigma was 2.76 [95% confidence interval (CI) = 2.60-2.94], experienced stigma 2.29 [95% CI = 2.18, 2.41], alienation 2.40 [95% CI = 2.29, 2.52], stereotype endorsement 2.14 [95% CI = 2.03, 2.27], social withdrawal 2.28 [95% CI = 2.17, 2.39] and stigma resistance 2.53 [95% CI = 2.43, 2.63]). Self-stigma levels did not reduce over time. Living outside urban areas, low-income, singleness, unemployment, high antipsychotic dose and low functioning were associated with different stigma dimensions. Some stigma dimensions were lower in studies carried out in Europe compared to other regions. Most studies published since 2007 report that self-stigma is a particular concern for a specific subgroup of patients. This subgroup is characterized by unemployment, high antipsychotic dose and low functioning. We identified important other missing factors that should be explored to improve the effectiveness of public policies and personalized interventions to reduce self-stigma. Importantly, classical illness severity indices (psychotic severity, age at illness onset, illness duration) and sociodemographic variables (age, sex and education) were not associated with self-stigma, moderating previous findings.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Fond G, Vidal M, Joseph M, et al. Self-stigma in schizophrenia: a systematic review and meta-analysis of 37 studies from 25 high- and low-to-middle income countries. Mol Psychiatry. 2023. PMID: 36890299. doi:10.1038/s41380-023-02003-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。